ADDC - AstraZeneca Collaboration

Contact Information:

Matthew Hartman

Academic Drug Discovery Consortium

Email: mhartman@addconsortium.org

For more information on Partnering With AstraZeneca http://www.astrazeneca.com/Partnering

Time Line
Fall 2017
Now accepting submissions for 2017. Deadline October 31st, 2017.
Fall 2017
Results anticipated December, 2017
Areas of Interest
Cardiovascular & Metabolic
Disease (CVMD)
Respiratory, Inflammation
& Autoimmune (R/A)
Oncology
Neuroscience